Fortis Healthcare Share Price
As on 13 June 2026 at 02:37 IST
Fortis Healthcare Q1 FY26 Results:
Net profit rose 53% to ₹267 crores, compared to ₹174 crores in Q1 FY25. Total income in Q1 FY26 increased 17% to ₹2,182 crores from ₹1,872 crores in the same period last year.
About Fortis Healthcare Ltd
Fortis Healthcare Ltd. is India's leading integrated healthcare delivery service provider. It operates in multi-specialty hospitals, diagnostic centers, and specialized care facilities. Fortis was founded in 1996 by Malvinder Singh and Shivinder Singh. The company underwent a significant change in 2018 when IHH Healthcare Berhad became its backing entity. It is headquartered in Mohali, Punjab. Fortis Healthcare offers comprehensive healthcare services. This includes multi-specialty hospital care, daycare specialty facilities, and diagnostic and emergency services. Operating in the Healthcare Services sector, Fortis manages a network of several healthcare facilities across India. +
The Current prices are delayed, log in for live prices
LOGINOver 1 Month
1.52%
Over 6 Months
15.56%
Over 1 Year
29.41%
Over 3 Years
248.30%
Fortis Healthcare Ltd Summary
Close ₹989
Open ₹983.15
High ₹998.50
Low ₹977.80
Volume 7,84,738
Net Turnover (in Cr) ₹77.53
52Wk High ₹1,104.30
52Wk Low ₹742.20
52Wk High / Low
742.20
1,104.30
Fortis Healthcare Ltd Fundamentals
Key Financial Data
Market Cap (in Cr) ₹74,665.36
EPS (TTM) 2.70
Book Value (BV) 122.24
Div. Yield 0.10 %
P/E (TTM) 324.25
Price/Book Value 8.09
Delivery % 45.19 %
Face Value 10
Key Ratios
PE Ratio 831.55
PB Ratio 5.81
EV to Sales 36.32
PEG Ratio -12.20
ROA 0.57
ROE 1.41
Debt-Equity 0.15
Net Profit Margin 8.49
Operating Profit Margin 30.13
Fortis Healthcare Ltd Financials
Profit and Loss
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Total Revenue | 7,849.69 | 6,931.17 | 6,359.35 | 5,744.95 | 4,076.68 |
| Total Expenses | 6,764.83 | 6,098.73 | 5,641.12 | 5,096.34 | 4,082.15 |
| Profit Before Tax | 1,007.05 | 857.97 | 813.68 | 987.79 | 43.30 |
| Profit After Tax | 809.38 | 645.22 | 632.98 | 789.95 | -56.17 |
| Operating Profit After Depreciation | 1,269.28 | 963.38 | 847.32 | 795.45 | 160.41 |
Balance Sheet
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Fixed Assets | 10,426.41 | 9,875.18 | 9,426.48 | 9,415.75 | 8,800.86 |
| Total Non Current Assets | 12,220.17 | 11,868.19 | 11,027.25 | 10,751.48 | 10,117.88 |
| Total Current Assets | 1,471.36 | 1,420.59 | 1,406.35 | 1,133.27 | 1,036.80 |
| Total Assets | 13,691.53 | 13,288.78 | 12,433.60 | 11,884.75 | 11,154.69 |
| Total Shareholder's Fund | 8,916.52 | 7,662.90 | 7,242.26 | 6,178.24 | 6,119.81 |
Cash Flow
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Net Cash From Operating Activities | 1,423.93 | 1,100.10 | 822.25 | 865.39 | 485.49 |
| Net Cash Used In Investing Activities | -779.84 | -889.12 | -372.48 | -500.61 | -130.55 |
| Net Cash Used In Financing Activities | -713.85 | -86.46 | -471.22 | -517.31 | -142.93 |
Profit and Loss
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Total Revenue | 1,644.44 | 1,324.43 | 1,202.50 | 996.71 | 824.85 |
| Total Expenses | 1,414.88 | 1,171.51 | 1,141.90 | 989.41 | 857.18 |
| Profit Before Tax | 114.41 | 246.56 | 108.88 | -8.99 | 24.13 |
| Profit After Tax | 63.78 | 199.45 | 96.24 | -13.25 | 4.20 |
| Operating Profit After Depreciation | 341.14 | 234.83 | 166.84 | 136.87 | 109.12 |
Balance Sheet
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Fixed Assets | 925.05 | 468.13 | 491.86 | 770.28 | 853.25 |
| Total Non Current Assets | 11,609.13 | 9,745.42 | 9,678.55 | 10,020.52 | 10,196.70 |
| Total Current Assets | 389.93 | 641.50 | 690.12 | 405.69 | 385.44 |
| Total Assets | 11,999.06 | 10,386.91 | 10,368.67 | 10,426.21 | 10,582.14 |
| Total Shareholder's Fund | 9,074 | 9,087.16 | 8,963.54 | 8,868.56 | 8,881.53 |
Cash Flow
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Net Cash From Operating Activities | 334.02 | 218.45 | 198.38 | 76.49 | 31.94 |
| Net Cash Used In Investing Activities | -1,572.21 | 44.46 | 204.62 | 237.74 | 28.40 |
| Net Cash Used In Financing Activities | 1,275.91 | -245.35 | -395.43 | -319.83 | 5.91 |
| Particulars (in ₹ Cr.) | 2026-03 | 2025-12 | 2025-09 | 2025-06 | 2025-03 |
|---|---|---|---|---|---|
| Total Revenue | 2,364.67 | 2,265.01 | 2,331.44 | 2,166.72 | 2,007.20 |
| Total Expenses | 1,832.34 | 1,759.36 | 1,775.11 | 1,676.05 | 1,571.73 |
| Profit Before Tax | 324.20 | 265.68 | 425.40 | 350.57 | 236.55 |
| Profit After Tax | 271.19 | 197.40 | 328.82 | 266.78 | 188.02 |
| Operating Profit after Depreciation | 542.94 | 517.47 | 582.59 | 508.99 | 459.91 |
| Particulars (in ₹ Cr.) | 2026-03 | 2025-12 | 2025-09 | 2025-06 | 2025-03 |
|---|---|---|---|---|---|
| Total Revenue | 460.73 | 442.93 | 455.81 | 433.03 | 388.47 |
| Total Expenses | 350.42 | 344.17 | 355.93 | 344.92 | 317.51 |
| Profit Before Tax | 37.37 | 34.18 | 134.98 | 62.97 | -38.90 |
| Profit After Tax | 24.98 | 28.40 | 125.09 | 51.88 | -42.23 |
| Operating Profit after Depreciation | 126.84 | 114.98 | 192.30 | 128.12 | 95.95 |
Fortis Healthcare Ltd Technicals
Support and Resistance
S3 S2 S1 Pivot R1 R2 R3
S1 978.37
S2 967.73
S3 957.67
Pivot 988.43
R1 999.07
R2 1,009.13
R3 1,019.77
Moving Average
20 SMA 962.03
50 SMA 922.09
100 SMA 899.27
200 SMA 927.94
Fortis Healthcare Ltd Corporate Actions
Fortis Healthcare Ltd
₹1.0/Share
Announcement Date 25 Jul 2025
Record Date 25 Jul 2025
Div Yield 10%
Fortis Healthcare Ltd Peer Comparison
| Company | Price | Market Cap (in Cr) |
|---|---|---|
| Apollo Hospitals Enterprise Ltd | ₹8,495.95 | ₹1,22,158.73 |
| Max Healthcare Institute Ltd | ₹1,008.95 | ₹98,195.43 |
| Aster DM Healthcare Ltd | ₹814.20 | ₹42,185.41 |
| Narayana Hrudayalaya Ltd | ₹1,861.80 | ₹38,047.89 |
| Global Health Ltd | ₹1,228.60 | ₹33,033.10 |
Fortis Healthcare Ltd Top Mutal Funds Invested
| Fund Name | AUM |
|---|---|
| Kotak Midcap Fund | 4.03% |
| AXIS Midcap Fund | 3.54% |
| Kotak Aggressive Hybrid | 3.43% |
| HDFC Mid Cap Fund | 3.09% |
| DSP Midcap Fund | 2.70% |
Fortis Healthcare Ltd News
Board of Fortis Healthcare recommends final dividend
Of Rs 1 per share
23 May 2026, 10:53 am
Fortis Healthcare to discuss results
On 22 May 2026
16 May 2026, 05:33 pm
Fortis Healthcare schedules board meeting
On 13 February 2026
06 Feb 2026, 05:21 pm
Fortis Healthcare expands presence in Bengaluru with acquisition of TMI Healthcare
20 Dec 2025, 11:05 am
Fortis Healthcare to invest around Rs 840 crore to add 300 plus beds in Bengaluru
Company acquires People Tree Hospital Yeshwanthpur for Rs 430 crore, plans further Rs 410 crore capex to scale operations.
20 Dec 2025, 09:06 am
Fortis Healthcare Ltd Stock Analysis
- Annual revenue for Fortis Healthcare Ltd increased by 24.16% to ₹1,644.44 crore in FY 2025 from ₹1,324.43 crore in FY 2024.
- Annual Net Profit for Fortis Healthcare Ltd decreased by 68.02% to ₹63.78 crore in FY 2025 from ₹199.45 crore in FY 2024.
- Promoter Shareholding in Fortis Healthcare Ltd remains unchanged by 0.00% in the most recent quarter, from 31.17% in December 2025 to 31.17% in March 2026.
- Fortis Healthcare Ltd delivered a 1-year return of 29.41% compared to the Nifty 50, which provided a return of -7.87% as of the last trading session.
- Fortis Healthcare Ltd share price moved up by 0.48% from its previous close of INR ₹989. The latest Fortis Healthcare Ltd share price is INR ₹993.70.
- Fortis Healthcare Ltd share price today has been at a low of 989 and a high of 1,002. Over the past 52 weeks, the Fortis Healthcare Ltd share price has seen a low of 742.20 and a high of 1,104.30.
About Fortis Healthcare Ltd
Fortis Healthcare Ltd. is India's leading integrated healthcare delivery service provider. It operates in multi-specialty hospitals, diagnostic centers, and specialized care facilities. The company is especially operating in the Hospital & Healthcare Services industry.
Fortis Healthcare was founded in 1996 by Malvinder Singh and Shivinder Singh. The company has been providing healthcare services for many decades. Following a change in ownership in 2018, the company is now backed by IHH Healthcare Berhad, one of Asia's largest healthcare groups. Fortis Healthcare is headquartered in Mohali, Punjab, India.
The promoter shareholding of the company is 31.17%. The company's promoter is Northern TK Venture Pte Ltd., a subsidiary of IHH Healthcare Berhad. The company offers a comprehensive range of healthcare services. This includes multi-specialty hospital care, Diagnostic services, and Daycare specialty facilities. It also offers emergency services, critical care, preventive health programs, and organ transplantation.
Fortis Healthcare is among the top private healthcare providers in India. But it ranks second in terms of market capitalization after Apollo Hospitals Enterprise Ltd. The company operates a network of many healthcare facilities with approximately 4,000 operational beds across India.
The company's registered office is at Fortis Hospital, Sector 62, Phase VIII, Mohali, Punjab - 160062. Its registrar is located in Hyderabad, Telangana. The registrar & transfer agent of Fortis Healthcare is KFin Technologies Limited. Ravi Rajagopal is the company's chairperson and independent director. The company's other vital managerial promoters include:
Healthcare Access and Infrastructure Impact Fortis has significantly impacted healthcare accessibility in India through its network of many hospitals across major cities and tier-2 locations. The company has brought world-class medical infrastructure to various regions. This reduces the need for patients to travel long distances for quality healthcare. Its presence has particularly impacted emergency and critical care services. This is because Fortis's many facilities operate 24/7 emergency departments. The company's strategic location of hospitals has helped create medical hubs in various cities. This improves the overall healthcare infrastructure of these regions.
Medical Excellence and Specialized Care The company has made a substantial impact in bringing specialized medical treatments to India. Fortis has pioneered several complex procedures and treatments. This includes organ transplants, cardiac surgeries, and oncology treatments. Its centers of excellence have set new benchmarks in specialized care. These specialized cares are particularly in cardiology, orthopedics, neurosciences, and oncology. The company has also impacted medical tourism in India. It attracts patients from various countries and establishes India as a global healthcare destination.
Employment and Skill Development Fortis has created significant employment opportunities in the healthcare sector. It employs thousands of medical professionals, support staff, and administrative personnel. The company's impact extends to medical education and skill development through its training programs and partnerships with educational institutions. Its presence has helped develop a skilled healthcare workforce. This contributes to the overall growth of India's healthcare sector.
Technology and Innovation Impact The company has been instrumental in introducing cutting-edge medical technologies and innovative treatment methods in India. Fortis's adoption of robotic surgery, advanced imaging systems, and digital healthcare solutions has impacted the modernization of healthcare delivery. Its investments in healthcare technology have influenced other hospitals to upgrade their facilities. This leads to a significant improvement in healthcare technology standards across the country.
Community Health Impact Fortis has significantly impacted community health through its preventive healthcare programs and health awareness initiatives. The company's outreach programs have helped educate communities about various health issues, preventive care, and lifestyle diseases. Its impact on public health is particularly notable during health emergencies and pandemics, where Fortis facilities have played crucial roles in disease management and treatment.
Research and Development The company has impacted medical research through its clinical research programs and collaborations with international healthcare institutions. Fortis's participation in global medical trials and research studies has contributed to the advancement of medical knowledge and treatment protocols. Its research initiatives have particularly affected the understanding and treatment of diseases specific to the Indian population.
Fortis Healthcare's impact on India's healthcare sector extends far beyond its business operations. The company has played a transformative role in modernizing healthcare delivery. Also, it is improving access to quality medical care and setting new standards for medical excellence. Its contributions to employment, medical education, research, and community health have created lasting positive changes in the healthcare ecosystem. As the company continues to expand and innovate, its impact is likely to grow further, particularly in addressing India's healthcare challenges and improving the overall quality of healthcare services. The company's journey demonstrates how private healthcare providers can significantly contribute to a country's healthcare development while maintaining sustainable business operations.
Fortis Healthcare was founded in 1996 by Malvinder Singh and Shivinder Singh. The company has been providing healthcare services for many decades. Following a change in ownership in 2018, the company is now backed by IHH Healthcare Berhad, one of Asia's largest healthcare groups. Fortis Healthcare is headquartered in Mohali, Punjab, India.
The promoter shareholding of the company is 31.17%. The company's promoter is Northern TK Venture Pte Ltd., a subsidiary of IHH Healthcare Berhad. The company offers a comprehensive range of healthcare services. This includes multi-specialty hospital care, Diagnostic services, and Daycare specialty facilities. It also offers emergency services, critical care, preventive health programs, and organ transplantation.
Fortis Healthcare is among the top private healthcare providers in India. But it ranks second in terms of market capitalization after Apollo Hospitals Enterprise Ltd. The company operates a network of many healthcare facilities with approximately 4,000 operational beds across India.
The company's registered office is at Fortis Hospital, Sector 62, Phase VIII, Mohali, Punjab - 160062. Its registrar is located in Hyderabad, Telangana. The registrar & transfer agent of Fortis Healthcare is KFin Technologies Limited. Ravi Rajagopal is the company's chairperson and independent director. The company's other vital managerial promoters include:
- Ashutosh Raghuvanshi
- Suvalaxmi Chakraborty
- Indrajit Banerjee
- Shailaja Chandra
Impact of the Company
Fortis Healthcare has significantly impacted India's healthcare landscape since its inception. The company has transformed healthcare delivery through its integrated approach, technological advancements, and commitment to quality medical care. Its presence across multiple cities has improved healthcare accessibility. Also, it has introduced international standards of medical care to the Indian healthcare sector.Healthcare Access and Infrastructure Impact Fortis has significantly impacted healthcare accessibility in India through its network of many hospitals across major cities and tier-2 locations. The company has brought world-class medical infrastructure to various regions. This reduces the need for patients to travel long distances for quality healthcare. Its presence has particularly impacted emergency and critical care services. This is because Fortis's many facilities operate 24/7 emergency departments. The company's strategic location of hospitals has helped create medical hubs in various cities. This improves the overall healthcare infrastructure of these regions.
Medical Excellence and Specialized Care The company has made a substantial impact in bringing specialized medical treatments to India. Fortis has pioneered several complex procedures and treatments. This includes organ transplants, cardiac surgeries, and oncology treatments. Its centers of excellence have set new benchmarks in specialized care. These specialized cares are particularly in cardiology, orthopedics, neurosciences, and oncology. The company has also impacted medical tourism in India. It attracts patients from various countries and establishes India as a global healthcare destination.
Employment and Skill Development Fortis has created significant employment opportunities in the healthcare sector. It employs thousands of medical professionals, support staff, and administrative personnel. The company's impact extends to medical education and skill development through its training programs and partnerships with educational institutions. Its presence has helped develop a skilled healthcare workforce. This contributes to the overall growth of India's healthcare sector.
Technology and Innovation Impact The company has been instrumental in introducing cutting-edge medical technologies and innovative treatment methods in India. Fortis's adoption of robotic surgery, advanced imaging systems, and digital healthcare solutions has impacted the modernization of healthcare delivery. Its investments in healthcare technology have influenced other hospitals to upgrade their facilities. This leads to a significant improvement in healthcare technology standards across the country.
Community Health Impact Fortis has significantly impacted community health through its preventive healthcare programs and health awareness initiatives. The company's outreach programs have helped educate communities about various health issues, preventive care, and lifestyle diseases. Its impact on public health is particularly notable during health emergencies and pandemics, where Fortis facilities have played crucial roles in disease management and treatment.
Research and Development The company has impacted medical research through its clinical research programs and collaborations with international healthcare institutions. Fortis's participation in global medical trials and research studies has contributed to the advancement of medical knowledge and treatment protocols. Its research initiatives have particularly affected the understanding and treatment of diseases specific to the Indian population.
Fortis Healthcare's impact on India's healthcare sector extends far beyond its business operations. The company has played a transformative role in modernizing healthcare delivery. Also, it is improving access to quality medical care and setting new standards for medical excellence. Its contributions to employment, medical education, research, and community health have created lasting positive changes in the healthcare ecosystem. As the company continues to expand and innovate, its impact is likely to grow further, particularly in addressing India's healthcare challenges and improving the overall quality of healthcare services. The company's journey demonstrates how private healthcare providers can significantly contribute to a country's healthcare development while maintaining sustainable business operations.
FAQ’s
What is the share price of Fortis Healthcare Ltd today?
Fortis Healthcare Ltd share price as on 12 Jun 2026 is ₹ 993.7
What is the Market Cap of Fortis Healthcare Ltd?
The market cap of Fortis Healthcare Ltd stock is ₹74,665.36 Cr.
What is the PE Ratio of Fortis Healthcare Ltd?
The Price to Earnings (P/E) Ratio of Fortis Healthcare Ltd is 831.55
What is the PB Ratio of Fortis Healthcare Ltd?
The Price to Book (P/B) Ratio of Fortis Healthcare Ltd is 5.81
What is the 52 week high of Fortis Healthcare Ltd Share Price?
The 52 week high of Fortis Healthcare Ltd share price stands at ₹1,104.30
What is the 52 week low of Fortis Healthcare Ltd Share Price?
The 52 week low of Fortis Healthcare Ltd share price stands at ₹742.20
How can I buy shares of Fortis Healthcare Ltd?
Simply open a demat account with Torus Digital and place an order to buy shares of Fortis Healthcare Ltd.
Open FREE
3-in-1 Account
for all your banking, trading and demat needs
Trade in stocks,
derivatives and F&O
